1. Home
  2. TRUP vs NVCR Comparison

TRUP vs NVCR Comparison

Compare TRUP & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trupanion Inc.

TRUP

Trupanion Inc.

HOLD

Current Price

$23.11

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$18.09

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRUP
NVCR
Founded
2000
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
TRUP
NVCR
Price
$23.11
$18.09
Analyst Decision
Buy
Buy
Analyst Count
5
6
Target Price
$45.80
$28.08
AVG Volume (30 Days)
365.3K
1.7M
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
295.65
21.79
EPS
0.11
N/A
Revenue
$1,439,305,000.00
$655,353,000.00
Revenue This Year
$11.79
$7.72
Revenue Next Year
$8.83
$6.74
P/E Ratio
$202.55
N/A
Revenue Growth
11.95
8.28
52 Week Low
$21.92
$9.82
52 Week High
$57.35
$20.05

Technical Indicators

Market Signals
Indicator
TRUP
NVCR
Relative Strength Index (RSI) 38.00 69.12
Support Level N/A $12.66
Resistance Level $29.24 $18.92
Average True Range (ATR) 1.34 1.03
MACD -0.30 0.16
Stochastic Oscillator 16.96 87.89

Price Performance

Historical Comparison
TRUP
NVCR

About TRUP Trupanion Inc.

Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue majorly from subscription fees related to the company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions. Geographically, the company operates in United States, which derives maximum revenue; and Canada and Others.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: